Abstract
Head and neck squamous cell carcinoma (HNSCC) is a significant global health challenge, with high locoregional failure rates and poor treatment responses. Clinical outcomes with the combination of radiotherapy (RT) and immunotherapy remain unsatisfactory, largely due to resistance mechanisms within the tumor microenvironment (TME). One of such mechanisms involves extracellular vesicles (E…